Schultze Special Purpose Drops a “Teaser” Ahead of Extension Vote
by Kristi Marvin on 2020-06-01 at 11:16am

We have another teaser….this morning, Schultze Special Purpose Acquisition Corp. (SAMA), announced ahead of their forthcoming deadline extension vote that they have signed a non-binding LOI with Clever Leaves, a multi-national cannabis operator.

Interestingly, this is not a teaser where the SPAC makes you guess who they’re buying.  Instead, SAMA is stating exactly who it is they’re negotiating with and have even provide quotes from Clever Leave’s CEO.  This deal sounds fully-baked and yet they still do not have signed a definitive agreement. Perhaps Clever Leaves is waiting to see the results of the extension vote and how much cash is left in trust before they commit to terms. However, without a signed definitive agreement, we can’t technically move SAMA into the “announced” column just yet.

Nevertheless, today’s press release did provide some information on the intended target.  Clever Leaves operates globally with operations and facilities in Colombia, Portugal, the United States, Canada and Germany, producing pharmaceutical grade cannabis. The Company currently cultivates in over 1.9 million square feet of greenhouses, making it one of the largest cannabis cultivation and extraction companies globally.  Clever Leaves is also in the process of becoming one of the few cannabis companies in the world, and the only cannabis company in Latin America, to be granted a European Union Good Manufacturing Practice (“EU GMP”) certification for extracts, subject to successful completion of the certification process.

We currently have seven cannabis-focused SPACs out searching for targets, but it appears SAMA, which initially intended to focus on restructured companies, beat them all to announcing a cannabis combination.  To-date, only MTech (now Akerna – KERN) has closed a cannabis combination.  Although, Akerna was only “cannabis-adjacent” since it provided compliance technology to the sector, i.e., it was not involved in production or distribution.  If SAMA does “definitively” announce and this looks like a good deal, this could be the shot in the arm the rest of the field needs to announce their own cannabis deals. A “contact high”, so to speak.

SAMA goes to a vote next Tuesday, June 9th, and it sounds like we can expect a full announcement and definitive agreement shortly thereafter.  We’ll have to wait and see.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-24 at 4:09pm

Israeli tech firms have made up an outsized proportion of SPAC activity and despite the ongoing tensions in its region, that dealmaking is continuing unabated. In fact, the SPAC named for the particular mission of taking Israeli firms public through SPACs, Israel Acquisition Corp. (NASDAQ:ISRL) in fact just took one step closer in completing that...

by Nicholas Alan Clayton on 2024-04-24 at 8:07am

At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...

by Nicholas Alan Clayton on 2024-04-23 at 4:05pm

Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...

by Nicholas Alan Clayton on 2024-04-23 at 7:50am

At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...

by Nicholas Alan Clayton on 2024-04-22 at 3:01pm

With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved